Navigation Links
Alsius Corporation to Host First Quarter 2008 Financial Results Conference Call on May 15, 2008
Date:5/8/2008

IRVINE, Calif., May 8 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it will hold a conference call to discuss the Company's first quarter results and provide a corporate update. Bill Worthen, president and CEO, and Brett Scott, CFO, will host the call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Thursday, May 15. A press release for the first quarter ended March 31, 2008 will be released following the market close on May 15.

To participate in the live call by telephone, please dial 877-545-1489 from the U.S. or +1-719-325-4930 for international callers. In addition, the live conference call is being webcast and can be accessed via the "Investor Relations" section of the Company's website at http://www.alsius.com. Beginning 90 minutes after the conference call concludes, a replay will be available on Alsius' website or by dialing 888-203-1112 from the U.S. or +1-719-457-0820 internationally, and entering passcode 3084937 when prompted. The telephone replay will be available through May 31, 2008.

About Alsius

Alsius, headquartered in Irvine, Calif., is a medical device company that develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address
'/>"/>

SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
2. Mac-Gray Corporation Announces First-Quarter 2008 Financial Results
3. MannKind Corporation Reports First Quarter Financial Results
4. Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
5. BioElectronics Corporation Receives Major Orders From Italian Distributor
6. Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
7. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
8. Syndexa Pharmaceuticals Corporation and ChemDiv, Inc. Announce Discovery Collaboration
9. Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
10. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
11. LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Chicago, IL (PRWEB) November 21, 2014 ... technology competitors at the 2014 Emerging Medical Technologies Summit ... MedTech Innovator Awards. Widely regarded among Silicon Valley ... emerging medical device innovation, the win also positions Briteseed ... the MedTech Innovator competition in 2015 and compete with ...
(Date:11/22/2014)... Rapids, MI (PRWEB) November 22, 2014 ... opportunity to simulate the proper management of life-like ... and test lung devices . Grand Rapids-based, Michigan ... plans to donate two of the respiratory simulation ... to $15,000 each. Grand Valley and Muskegon Community ...
(Date:11/22/2014)... , November 21, 2014 ... wechselt als Chief Commercial Officer zu KLOX    ... der Unternehmensentwicklung und Chief Financial Officer bestellt    ... mit der Vermarktung seines jüngst zugelassenen Behandlungssystems zur Wundheilung ... ("KLOX" bzw. das "Unternehmen") ist sehr erfreut, die folgenden ...
(Date:11/21/2014)... --  TRU-D SmartUVC LLC and its UK partners, Rapid ... robot, TRU-D SmartUVC, at FIS 2014 in Harrogate, ... at Stand 23. The conference, hosted by Federation ... largest infection-related event of its kind and brings together ... leading events of its type throughout the world. This annual ...
Breaking Biology Technology:Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 2TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 3
... ... with the Gwendolyn Strong Foundation on a fundraising campaign for spinal muscular atrophy gene ... (PRWEB) ... for SMA gene therapy, “Realizing the Dream.” FightSMA is collaborating with the Santa ...
... CHICAGO , July 8 Advanced Life Sciences Holdings, ... discovery, development and commercialization of novel drugs in the therapeutic areas ... preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of ... setting. , , , ...
... SAN FRANCISCO , July 7 The Real Staffing Group, a ... launched new offices in New York and San Francisco . ... this occasion by launching a new app for the iPhone. This app provides ... and Europe . , , ...
Cached Biology Technology:FightSMA Launches Gene Therapy Fundraising Campaign: “Realizing the Dream” 2FightSMA Launches Gene Therapy Fundraising Campaign: “Realizing the Dream” 3FightSMA Launches Gene Therapy Fundraising Campaign: “Realizing the Dream” 4Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use 2Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use 3Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use 4A Real First for Pharma Jobs Across the Globe 2
(Date:11/6/2014)... Insilico Medicine, Inc, a Baltimore-based bioinformatics company focused ... announced a research collaboration with the international leader ... (OTC: CSBR). , "There are many companies utilizing ... Oncology,s TumorGraft technology is unique in a way ... generating vast amounts of valuable data. Our bioinformatic ...
(Date:11/4/2014)... the right amount of death at the right time ... to new research that could help in understanding animal ... , In a paper in the journal Trends ... and European colleagues conclude that the kind of positive ... of individuals, or mortality, depends on the size and ...
(Date:11/4/2014)... of Madagascar,s 101 species of lemurs are threatened with ... rainforests they call home. A new study by Rice ... on rainforest tree populations, which raises concerns about the ... rich biodiversity. , A large proportion of trees in ... in turn disperse the seeds of their fruit trees ...
Breaking Biology News(10 mins):Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... Rochester Medical Center have uncovered a promising drug therapy ... Batten disease a rare neurodegenerative disease that strikes ... to see, reason and move, and ultimately kills them ... the January edition of Experimental Neurology, explains how investigators ...
... to eat at the holidays: Dont take your cues from ... Pole resident eats are a no-no. But you dont have ... University of Florida researchers say. In fact, many ... according to findings from a UF paper published recently in ...
... work better on some children than on others, but judging ... no simple task. Now researchers have developed a new mathematical ... treat children who are abnormally short for a wide range ... access journal BMC Medical Informatics and Decision Making describes a ...
Cached Biology News:Research unveils new hope for deadly childhood disease 2Too much fructose could leave dieters sugar shocked 2Too much fructose could leave dieters sugar shocked 3
... expression vectors, we in-troduced a new concept, namely ... tran-scriptional level at the T7 phage promoter, and ... the plasmid copy number, The main advantage of ... practically all of the outstanding features of the ...
... Anti Nop1p/Fibrillarin (monoclonal) Nop1p/Fibrillarin ... protein of bakers yeast, Saccharomyces cerevisiae ... essential for yeast viability and is ... homologue of Nop1p is fibrillarin (accession ...
... protein crystallography involves using many of the ... The liquid handling requirements are similar to ... crystallography plates have 24 or 48 wells ... For higher throughput, the number of wells ...
... The Reverse-iT™ One-Step Kit is the ... in RT-PCR. It has been specifically ... The Reverse-iT™ One-Step Kit combines ... and ABgene®s Thermoprime Plus DNA Polymerase ...
Biology Products: